To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
Languages
Recent
Show all languages
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
.
Leo
Newton
Brights
Milds

Office of the Gene Technology Regulator

From Wikipedia, the free encyclopedia

The Office of the Gene Technology Regulator supports the Gene Technology Regulator (the Regulator), and is a part of the Australian Government Department of Health and Ageing. The Office was established under the Commonwealth Gene Technology Act 2000 (the Act). This legislation sets forth a nationally consistent regulatory system for gene technology in Australia.

In Australia, all dealings with live and viable genetically modified organisms (GMOs), including import, are illegal unless authorised under the Act.

The OGTR has developed a range of documents to provide organisations and interested parties with guidance on monitoring and compliance activities under the Act.

Under the act, the regulator may issue technical and procedural guidelines in relation to GMOs (under section 27 of the Act), in relation to certification of facilities to specified containment levels (section 90) and in relation to accreditation of organisations (section 98). The Act, the Gene Technology Regulations 2001 (the Regulations) or instruments issued by the Regulator can require compliance with these guidelines in conducting dealings with GMOs or in obtaining and maintaining certification or accreditation.

To ensure the necessary approvals or authorisations are obtained prior to importation, the OGTR is working closely with the Australian Quarantine and Inspection Service (AQIS) especially in relation to GM seeds/grains.

YouTube Encyclopedic

  • 1/3
    Views:
    1 154
    9 389
    15 720
  • Workings of an Alzheimer's Gene
  • Mod-08 Lec-29 Cloning and Expression vectors
  • Joseph Stiglitz: "Freefall" | Talks at Google

Transcription

>> DR. THOMAS LEHNER: The hope of the large-scale genetic studies is always, first, to find a signal. That is, to find a gene that's associated with a particular disorder - Alzheimer's in this case. And then, the next very difficult step is to then take this finding and move it forward into developing new drugs. Rudy Tanzi and his colleagues did exactly that. They took the finding and through a complex set of experiments in human brains, in cells, in mice - they actually could show, with strong confidence, that this gene and its product, is associated as a risk for Alzheimer's disease. The gene involved, according to the study, is called CD33. We know it's involved in immune function somehow. But we don't know what it does in the brain. It is expressed - the protein that's coded by CD is produced in cells in the brain that are called microglia. Microglia are support cells that protect the brain from infection - that have an immune function in the brain. CD33 is also involved in clearance of a protein beta-amyloid has long been associated with Alzheimer's. And CD33 helps to get rid of the over-production of that protein. The gene comes in two flavors. And it has been shown that one particular flavor is protective for Alzheimer's. And it also reduces the level of beta-amyloid that's present in the brain. If the expression of CD33 is reduced in those particular microglial cells - these protective, support cells that have immune function. If the expression is reduced, the cells themselves can take up higher quantities of beta-amyloid, and eliminate beta amyloid - thus protecting the brain from Alzheimer's. Until today, very few genetic signals have been found that increase the risk for Alzheimer's disease. Now, through large-scale genomic studies of recent years, we have a few more. Not too many, maybe three or four. This is one of those. One of the reasons this finding is so exciting is that it opens a potential pathway to develop treatments. You could imagine that if there was a drug developed that crosses the blood-brain barrier - which is an additional difficulty - that oppresses the expression of that particular gene, that may be protective for Alzheimer's. But his is, you know, far. This is nothing that is imminent. This is a long process of drug development.

The regulator

The regulator is an independent statutory office holder responsible for administering the Gene Technology Act 2000 (the Act) and corresponding state and territory laws. The regulator is appointed by the governor-general only with the agreement of the majority of all jurisdictions. She is responsible for administering the national regulatory system for gene technology as set out in the Act. The OGTR staff are part of the Department of Health.

Office-holders

Dr Raj Bhula is the current Gene Technology Regulator, appointed for a period of five years commencing 18 July,. Bhula has over 20 years experience in regulation of pesticides in Australia. She was Executive Director of Scientific Assessment and Chemical Review at the Australian Pesticides and Veterinary Medicines Authority and Program Manager Pesticides for almost 10 years. Bhula represented Australia at international expert committees incl,uding as the Codex Committee for Pesticide Residues and contributed to technical groups of the OECD Working Group on Pesticides. Much of this work has included the development of technical policy and risk assessment methodologies.

The regulator's roles and functions

In administering the gene technology regulatory system the Regulator has specific responsibility to protect the health and safety of people, and to protect the environment, by identifying risk posed by or as a result of gene technology, and by managing those risks through regulating certain dealings with GMOs.

Section 27 of the act sets out the functions of the regulator to:

  • perform functions in relation to GMO licences as set out in the act (Part 5), which outlines the licensing system under which a person can apply to the Regulator for a licence authorising dealings with GMOs
  • develop
    • draft policy principles and policy guidelines, as requested by the LGFGT
    • codes of practice
  • issue technical and procedural guidelines in relation to GMOs
  • provide information and advice to
    • other regulatory agencies, about GMOs and GM products
    • the public, about the regulation of GMOs
    • the Legislative Governance Forum on Gene Technology about the
      • operations of the Regulator and the Gene Technology Technical Advisory Committee
      • effectiveness of the legislative framework for the regulation of GMOs, including in relation to possible amendments of relevant legislation
  • undertake or commission research in relation to risk assessment and the biosafety of GMOs
  • promote the harmonisation by regulatory agencies of risk assessments relating to GMOs and GM products
  • monitor international practice in relation to the regulation of GMOs
  • maintain links with international organisations that deal with the regulation of gene technology and with agencies that regulate GMOs in countries outside Australia
  • conduct other functions conferred by the Act, the Regulations or any other law, such as
    • monitoring and enforcing the legislation
    • reporting quarterly to the minister and Federal Parliament.

Governance arrangements

The Act and Regulations and corresponding state and territory laws provide a nationally consistent system to regulate development and use of gene technology in Australia. The legislation establishes the Regulator as an independent statutory office holder to administer the national scheme. Under the intergovernmental Gene Technology Agreement, the states and territories have committed to maintaining corresponding legislation with the Commonwealth. The Regulator is charged with performing functions and exercising powers under the Act and corresponding legislation.

While the Regulator must consider risks to human health and safety and the environment relating to dealings with GMOs, other agencies have responsibility for regulating GMOs or genetically modified (GM) products as part of a broader or different mandate. During development of the gene technology legislation, it was determined that the Regulator's activities should form part of an integrated legislative framework that also includes a number of other regulatory authorities with complementary responsibilities and expertise. This arrangement both enhances coordinated decision-making and avoids duplication. The Gene Technology Act was accompanied by consequential amendments of the other relevant Acts relating to requirements for reciprocal request and provision of advice and exchange of information between the Regulator and other relevant regulatory agencies. These requirements include the following:

  • the Regulator must consult Commonwealth regulatory agencies prescribed in the Regulations on all licence applications for dealings involving the intentional release of GMOs to the environment
  • there are requirements for agencies regulating GM products to consult and/or notify the Regulator regarding applications for registration of products that are GM or contain GMOs.

These provisions support an adequate and timely flow of information between the agencies to inform assessments and decisions. (Accordingly, where other agencies approve GM products, they seek advice from the Regulator and provide notification of their decisions to the Regulator for inclusion on the GMO Record.)

References

External links

This page was last edited on 10 May 2024, at 11:06
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.